The association of indoxyl sulfate with fibroblast growth factor-23 in cats with chronic kidney disease
Open Access
- 18 February 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 33 (2) , 686-693
Abstract
Background Indoxyl sulfate (IS) has been reported not only to increase with the severity of impaired renal function, but also possibly to be a factor associated with bone abnormalities linked to fibroblast growth factor‐23 (FGF‐23) in humans with chronic kidney disease (CKD). It is not yet known whether this correlation between IS and FGF‐23 holds true for cats with CKD. Hypothesis Accumulation of IS is related to FGF‐23 secretion in cats with CKD. Animals Twenty clinically healthy cats and 73 cats with CKD cases were evaluated retrospectively. Methods The concentrations of IS and FGF‐23 in plasma were determined by high‐performance liquid chromatography and ELISA, respectively. Progression was defined as an increment of 0.5 mg/dL of serum creatinine concentration within 3 months. Results Plasma IS and FGF‐23 concentrations were significantly increased concurrently with decreasing renal function. Higher concentration of FGF‐23 was significantly associated with higher concentration of IS after adjusting for various confounding factors including creatinine and phosphate. Furthermore, the correlation between IS and phosphate was higher than that between FGF‐23 and phosphate. When the renal progression group was compared with the non‐progression group, both IS and FGF‐23 were found to be significantly increased (P < .05). In addition, the area under receiver operator curve of the combination of IS and FGF‐23 predicted renal progression at a level >0.9. Conclusions and Clinical Importance Both FGF‐23 and IS are associated with phosphate metabolism and CKD progression.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 107-2313-B-002-053)
- Ministry of Science and Technology, Taiwan (MOST 107‐2313‐B‐002‐053)
This publication has 24 references indexed in Scilit:
- Effects of FGF‐23‐mediated ERK/MAPK signaling pathway on parathyroid hormone secretion of parathyroid cells in rats with secondary hyperparathyroidismJournal of Cellular Physiology, 2018
- Plasma indoxyl sulfate concentration predicts progression of chronic kidney disease in dogs and catsThe Veterinary Journal, 2018
- Detection of indoxyl sulfate levels in dogs and cats suffering from naturally occurring kidney diseasesThe Veterinary Journal, 2015
- Indoxyl sulfate promotes apoptosis in cultured osteoblast cellsBMC Pharmacology and Toxicology, 2013
- p-cresylsulfate and indoxyl sulfate level at different stages of chronic kidney diseaseJournal of Clinical Laboratory Analysis, 2011
- p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney diseaseNephrology Dialysis Transplantation, 2010
- Regulation of Phosphate Homeostasis by PTH, Vitamin D, and FGF23Annual Review of Medicine, 2010
- Indoxyl Sulfate Reduces Superoxide Scavenging Activity in the Kidneys of Normal and Uremic RatsAmerican Journal of Nephrology, 2007
- Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2007
- Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-κB and free radical in proximal tubular cellsKidney International, 2003